[NEW VIEWPOINTS CONCERNING THE TREATMENT OF ACUTE TONSILLITIS].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000917:Antibody Formation; D004358:Drug Therapy; D005341:Fibrinolysin; D010406:Penicillins / Q000009:adverse effects* / Q000633:toxicity*; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D014069:Tonsillitis; D014116:Toxicology
D000614:Aminocaproates; D010406:Penicillins; D005341:Fibrinolysin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; ANTIBODY FORMATION; DRUG THERAPY; FIBRINOLYSIN; PENICILLIN TOXICOLOGY; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TONSILLITIS; TOXICOLOGIC REPORT
NEUE GESICHTSPUNKTE ZUR BEHANDLUNG DER AKUTEN TONSILLITIS.